Presentation
Jyothy Laboratories Ltd has submitted to BSE a copy of Presentation.16-02-2016
Intimation of Schedule of Analyst/ Institutional Investor Meet
Jyothy Laboratories Ltd has informed BSE regarding "Intimation of Schedule of Analyst/ Institutional Investor Meet".15-02-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
M P Ramachandran has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE05-02-2016
Spurred by Patanjali's success, Jyothy Labs builds on herbal' equity
To extend portfolio of heritage brands Neem, Margo30-01-2016
Shareholding for the Period Ended December 31, 2015
Jyothy Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here29-01-2016
Jyothy Labs Q3 net profit rises 47.4% to Rs38.99 crore
Net profit rose to Rs38.99 crore in the three month ended 31 December from Rs26.46 crore a year earlier28-01-2016
Results Press Release
Jyothy Laboratories Ltd has submitted to BSE a copy of Results Press Release for the period ended December 31, 2015.28-01-2016
Financial Results & Limited Review Report for Dec 31, 2015
Jyothy Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report (Standalone & Consolidated) for the period ended December 31, 2015.28-01-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Jyothy Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.13-01-2016
Intimation of Investor/ Analyst Call submitted on January 08, 2016
Jyothy Laboratories Ltd has informed BSE regarding "Intimation of Investor/ Analyst Call submitted on January 08, 2016".11-01-2016